Patel Sushil 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Patel Sushil（CIK 1860609）在 2 家公司共报告 18 笔 SEC Form 4 内部人交易（最近一笔 2026-08-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-12 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 卖出 | 39,341 | $510,253 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 买入 | 2,955 | $110,931 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 300 | $54,952 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 900 | $166,128 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 1,100 | $204,489 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 858 | $160,374 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 300 | $56,348 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 100 | $18,857 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 600 | $114,327 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 541 | $103,800 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | 董事 | 卖出 | 881 | $169,693 |
| 2026-06-23 | Revolution Medicines, Inc. (RVMD) | 董事 | 买入 | 1,191 | $0 |
| 2026-05-20 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 卖出 | 37,324 | $189,606 |
| 2026-04-07 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 买入 | 251,240 | $0 |
| 2025-12-19 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 买入 | 200,000 | $0 |
| 2025-12-04 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 卖出 | 10,000 | $111,300 |
| 2025-06-30 | Revolution Medicines, Inc. (RVMD) | 董事 | 买入 | 3,142 | $0 |
| 2025-05-22 | Replimune Group, Inc. (REPL) | Chief Executive Officer | 卖出 | 25,105 | $202,346 |
来源：SEC Form 4 申报文件 · 截至 2026-08-12